Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for Emergence Delirium in Pediatric Tonsillectomy
NCT03131375Phase 3Completed
- Sponsor
- Pan. & Aglaia Kyriakou Children's Hospital
- Start
- May 2017
- Primary completion
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in emergence delirium (ED) comparing Dexmedetomidine with Placebo (2 arms). Primary endpoint: Emergence delirium in PACU. Started May 2017; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
emergence delirium (ED)
Beyond the preview
Go deeper on NCT03131375.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03131375.